ISPC News and Press, iSpecimen Inc. From 02/10/22

LEXINGTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”) , an online marketplace for human biospecimens , today announced that Christopher Ianelli, MD, PhD, CEO and President, will participat...

LEXINGTON, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”) , an online marketplace for human biospecimens , today announced that it will report its financial results for the fourth quarter and ...

iSpecimen Expands Support of COVID-19 Research with Availability of Sequenced Specimens to Detect Variants Recent expansion of supplier capabilities will support commercial and government customers in their fight against COVID-19 PR Newswire LEXINGTON, Mass. , ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, Craig-Hallum initiated coverage of iSpecimen (NASDAQ: ISPC ) with a “buy” rating and a price target of $20. This price target represents impressive upside of more than 120% from current prices. ...

iSpecimen to Participate in the H.C. Wainwright BioConnect Conference on January 10-13, 2022 PR Newswire LEXINGTON, Mass. , Jan. 4, 2022 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human bios...

After adding more than a third of value on Tuesday, micro-cap stock iSpecimen (ISPC -17.5%) has lost sharply on below-average value. More than ~2.8M company shares have traded so far, compared to the 65-day average of ~5.3M. Despite a loss of more than a third since reaching a peak late last ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

iSpecimen Expands Global Biospecimen Supplier Network, Broadening Footprint Around the World Partners in Europe and Asia-Pacific satisfy a variety of urgent needs among life sciences research organizations PR Newswire LEXINGTON, Mass. , Dec. 16, 2021 /PRNewsw...

Gainers: Inspira Technologies (NASDAQ:IINN) +103%, Ensysce Biosciences (NASDAQ:ENSC) +53%, Jasper Therapeutics (NASDAQ:JSPR) +24%, Ambrx Biopharma (NYSE:AMAM) +17%, iSpecimen (NASDAQ:ISPC) +15%. Losers: Reata Pharmaceuticals (NASDAQ:RETA)...

Ensysce Biosciences (NASDAQ:ENSC) +83%. Inspira Technologies (NASDAQ:IINN) +59%. American Virtual Cloud Technologies (NASDAQ:AVCT) +29% announces significant projected revenue growth of Kandy, its cloud communications platform. Siyata Mobile (NASDAQ:SYTA) +28%. Digital Brands (NASDAQ:DBG...